Cook R - Search Results

1

Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial.

Tse P, Yan J, Liu Y, Jamula E, Heddle N, Bazin R, Robitaille N, Cook R, Turgeon A, Fergusson D, Glesby M, Loftsgard KC, Cushing M, Chassé M, Daneman N, Finzi A, Sachais B, Bégin P, Callum J, Arnold DM, Xie F. Tse P, et al. Among authors: cook r. Transfusion. 2024 Apr;64(4):606-614. doi: 10.1111/trf.17777. Epub 2024 Mar 21. Transfusion. 2024. PMID: 38511889 Clinical Trial.

2

Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19.

Bégin P, Callum J, Cook R, Jamula E, Liu Y, Finzi A; CONCOR-1 Study Group; Arnold DM. Bégin P, et al. Among authors: cook r. Nat Med. 2022 Jan;28(1):53-58. doi: 10.1038/s41591-021-01639-5. Epub 2022 Jan 10. Nat Med. 2022. PMID: 35013612 No abstract available.

3

Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial.

Heddle NM, Cook RJ, Blajchman MA, Barty RL, Sigouin CS, Boye DM, Nelson EJ, Kelton JG. Heddle NM, et al. Among authors: cook rj. Transfusion. 2005 Jun;45(6):896-903. doi: 10.1111/j.1537-2995.2005.04233.x. Transfusion. 2005. PMID: 15934987 Clinical Trial.

4

Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.

Cook RJ, Heddle NM, Rebulla P, Sigouin CS, Webert KE; Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society for Blood Transfusion. Cook RJ, et al. Transfusion. 2004 Aug;44(8):1135-42. doi: 10.1111/j.1537-2995.2004.03231.x. Transfusion. 2004. PMID: 15265116

5

Group O RBCs: where is universal donor blood being used.

Barty RL, Pai M, Liu Y, Arnold DM, Cook RJ, Zeller MP, Heddle NM. Barty RL, et al. Among authors: cook rj. Vox Sang. 2017 May;112(4):336-342. doi: 10.1111/vox.12492. Epub 2017 Mar 20. Vox Sang. 2017. PMID: 28321880

6

Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy.

Solh Z, Athale U, Arnold DM, Cook RJ, Foley R, Heddle NM. Solh Z, et al. Among authors: cook rj. Vox Sang. 2016 Oct;111(3):299-307. doi: 10.1111/vox.12419. Epub 2016 May 27. Vox Sang. 2016. PMID: 27231826

7

Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments.

Hayward CP, Pai M, Liu Y, Moffat KA, Seecharan J, Webert KE, Cook RJ, Heddle NM. Hayward CP, et al. Among authors: cook rj. J Thromb Haemost. 2009 Apr;7(4):676-84. doi: 10.1111/j.1538-7836.2009.03273.x. Epub 2009 Jan 17. J Thromb Haemost. 2009. PMID: 19143930 Free article.

8

Bleeding during critical illness: a prospective cohort study using a new measurement tool.

Arnold DM, Donahoe L, Clarke FJ, Tkaczyk AJ, Heels-Ansdell D, Zytaruk N, Cook R, Webert KE, McDonald E, Cook DJ. Arnold DM, et al. Among authors: cook r, cook dj. Clin Invest Med. 2007;30(2):E93-102. doi: 10.25011/cim.v30i2.985. Clin Invest Med. 2007. PMID: 17716547

9

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.

Mirasol Clinical Evaluation Study Group. Mirasol Clinical Evaluation Study Group. Transfusion. 2010 Nov;50(11):2362-75. doi: 10.1111/j.1537-2995.2010.02694.x. Transfusion. 2010. PMID: 20492615 Clinical Trial.

10

Using inverse-weighting in cost-effectiveness analysis with censored data.

Willan AR, Lin DY, Cook RJ, Chen EB. Willan AR, et al. Among authors: cook rj. Stat Methods Med Res. 2002 Dec;11(6):539-51. doi: 10.1191/0962280202sm308ra. Stat Methods Med Res. 2002. PMID: 12516988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,477 results

Search Page